Smart science to improve lives™
Open search Basket 0 View basket


Add to favourites
BB-BIONT™ protects the 4th skin layer, the microbiome. It selectively slows down the growth of Cutibacterium acnes and deconstructs its biofilm to avoid inflammatory skin damage. It also preserves the microbiome biodiversity promoting a healthy skin. BB-BIONT™ bans the cutaneous blemishes and helps to naturally achieve a flawless skin appearance.

INCI name

Please register or login to access these items

skin before applying BB-BIONT™ 1% After 2 months applying BB-BIONT™ 1%
Visualise the results

Healing the holobiont for a blemish-banned, smooth and healthy skin. 

BB-BIONT™ promotes the rebalance of the cutaneous microbiome. It helps avoid inflammation and pockmarks related to skin dysbiosis*. By rebalancing the skin’s microbiome, BB-BIONT clearly reduces inflammatory and post-inflammatory marks fading skin redness and evening the skin tone.

Application of a cream containing 1% BB-BIONT for 2 months on hemiface against placebo.

Use the slider to see the effect, simulation for illustration only.


skin before applying BB-BIONT™ 1% After 2 months applying BB-BIONT™ 1%
Visualise the results

2 independent clinical studies - Application of a cream containing 1% BB-BIONT™ for 2 months on hemiface against placebo.

1) 17 female and 1 male volunteers, mean age 32 [20-58]. Combination to oily skin with pockmarks and inflammatory marks.

2) 7 male and 23 female volunteers, mean age 24 [18-39]. Combination to oily skin with pockmarks, inflammatory marks and red or brown post-inflammatory marks.

A healthy skin microbiome:

Cutibacterium acnes after 1 month: -18.5%*/placebo
Staphylococcus epidermidis after 1 month: +15.4%**/placebo

Decrease of inflammatory marks

Number of inflammatory marks: -22%¤¤/placebo. 90% respondents

Number of post-inflammatory marks: -17 %¤¤¤/placebo. 87% respondents.

« I have less inflammatory marks »: 74.1%$ ¤¤/T0.


Soothing of inflammatory marks:

Maximum skin redness: -7%¤¤/placebo. 89% respondents.

Heterogeneity in skin redness: -6.6% ¤¤¤/placebo. 72% respondents.

« I have less post inflammatory marks »: 83%¤¤/T0

Smoothing of pockmarks:

Volume of pockmarks (mm3): -18.9%¤/placebo, 100% respondents.

Skin roughness (mm3), -6.5%¤/placebo, 100% respondents.

Volume of inflammatory marks (mm3) : -34.3%¤¤/placebo, 94% respondents.

Significance:*p<0.067 vs placebo
**non significant vs placebo

¤p<0.01, ¤¤p<0.05, ¤¤¤p<0.08 vs placebo

$ p<0.05/T0

Product details

Physical form at 25°C

  • Liquid


  • Peptides


  • Active ingredients

Regional availability

  • Asia
  • Europe
  • Latin America
  • N America


  • Skin care


  • Face / neck skin care

Consumer benefit

  • Repair
  • Smoothing
  • Antimicrobial
  • Calming / soothing / redness
  • Purifying
  • Radiance
  • Sensitive skin
  • Physiological balance

Certifications and standards

  • RSPO
  • Halal
  • Vegan suitable

Regional compliance

Want more information on a product?